These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24635575)

  • 1. Myeloid neoplasms with der(1)t(1;19) may constitute a specific entity characterized by a cytogenetic biomarker and gene mutations involved in DNA methylation.
    Salgado RN; Menezes J; Calvente M; Suela J; Acquadro F; Martínez-Laperche C; Flores R; Trujillo M; Alvarez S; Cigudosa JC
    Leuk Lymphoma; 2014 Nov; 55(11):2652-5. PubMed ID: 24635575
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
    Hartmann L; Haferlach C; Meggendorfer M; Kern W; Haferlach T; Stengel A
    Genes Chromosomes Cancer; 2019 Oct; 58(10):698-704. PubMed ID: 30994218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
    So CC; Ma ES; Wan TS; Yip SF; Chan LC
    Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
    Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
    Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.
    Bacher U; Weissmann S; Kohlmann A; Schindela S; Alpermann T; Schnittger S; Kern W; Haferlach T; Haferlach C
    Br J Haematol; 2012 Jan; 156(1):67-75. PubMed ID: 22017486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of acute myeloid leukemia based on levels of global hydroxymethylation.
    Kroeze LI; Aslanyan MG; van Rooij A; Koorenhof-Scheele TN; Massop M; Carell T; Boezeman JB; Marie JP; Halkes CJ; de Witte T; Huls G; Suciu S; Wevers RA; van der Reijden BA; Jansen JH;
    Blood; 2014 Aug; 124(7):1110-8. PubMed ID: 24986689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel reciprocal translocation between chromosomes 8 and 9 found in a patient with myeloproliferative disorder.
    Friedhoff F; Rajendra B; Moody R; Alapatt T
    Cancer Genet Cytogenet; 1983 Aug; 9(4):391-4. PubMed ID: 6575862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia.
    Jain P; Verstovsek S; Wang W; Loghavi S; Torres HA; Estrov Z; Patel KP; Pemmaraju N
    Leuk Lymphoma; 2016 Aug; 57(8):1969-73. PubMed ID: 26700872
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.
    Murga Penas EM; Cools J; Algenstaedt P; Hinz K; Seeger D; Schafhausen P; Schilling G; Marynen P; Hossfeld DK; Dierlamm J
    Genes Chromosomes Cancer; 2003 May; 37(1):79-83. PubMed ID: 12661008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel t(11;12)(q23-24;q24) in a case of minimally-differentiated acute myeloid leukemia (AML-M0).
    Cox MC; Scanzani A; Del Poeta G; Venditti A; Panetta P; Derme V; Sgro R; Masi M; Amadori S
    Cancer Genet Cytogenet; 2000 Apr; 118(1):76-9. PubMed ID: 10731597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-resolution banding in the cytogenetic analysis of chronic myeloid leukemia with a complex translocation].
    Aventín A; Mecucci C; Louwagie A; Schutyser J; Van den Berghe H
    Sangre (Barc); 1987; 32(1):6-11. PubMed ID: 3473696
    [No Abstract]   [Full Text] [Related]  

  • 13. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
    Damm F; Chesnais V; Nagata Y; Yoshida K; Scourzic L; Okuno Y; Itzykson R; Sanada M; Shiraishi Y; Gelsi-Boyer V; Renneville A; Miyano S; Mori H; Shih LY; Park S; Dreyfus F; Guerci-Bresler A; Solary E; Rose C; Cheze S; Prébet T; Vey N; Legentil M; Duffourd Y; de Botton S; Preudhomme C; Birnbaum D; Bernard OA; Ogawa S; Fontenay M; Kosmider O
    Blood; 2013 Oct; 122(18):3169-77. PubMed ID: 24047651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemia.
    Gozzetti A; Calabrese S; Raspadori D; Crupi R; Tassi M; Bocchia M; Fabbri A; Lauria F
    Cancer Genet Cytogenet; 2007 Aug; 177(1):81-2. PubMed ID: 17693199
    [No Abstract]   [Full Text] [Related]  

  • 15. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
    Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
    Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of chromosomes #1 and #11 in three cases with myeloproliferative diseases.
    Schmid E; Köhler J
    Cancer Genet Cytogenet; 1984 Jan; 11(1):121-3. PubMed ID: 6580942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cytogenetic analysis of complex karyotypes with derivative chromosome der(1)t(1;5) found in two patients with myeloid leukemia.
    Melichercíková J; Brezinová J; Zemanová Z; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2007 Jul; 176(2):150-5. PubMed ID: 17656259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation in TET2 in myeloid cancers.
    Delhommeau F; Dupont S; Della Valle V; James C; Trannoy S; Massé A; Kosmider O; Le Couedic JP; Robert F; Alberdi A; Lécluse Y; Plo I; Dreyfus FJ; Marzac C; Casadevall N; Lacombe C; Romana SP; Dessen P; Soulier J; Viguié F; Fontenay M; Vainchenker W; Bernard OA
    N Engl J Med; 2009 May; 360(22):2289-301. PubMed ID: 19474426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two new translocations that disrupt the AML1 gene.
    Richkind K; Hromas R; Lytle C; Crenshaw D; Velasco J; Roherty S; Srinivasiah J; Varella-Garcia M
    Cancer Genet Cytogenet; 2000 Oct; 122(2):141-3. PubMed ID: 11106827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new translocation, t(2;4;12)(p21;q12;p13), in CD7-positive acute myeloid leukemia: a variant form of t(4;12).
    Hamaguchi H; Nagata K; Yamamoto K; Kobayashi M; Takashima T; Taniwaki M
    Cancer Genet Cytogenet; 1999 Oct; 114(2):96-9. PubMed ID: 10549263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.